| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
21,103 |
15,885 |
$689K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,011 |
6,115 |
$251K |
| 99215 |
Prolong outpt/office vis |
916 |
791 |
$41K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,176 |
1,019 |
$33K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,745 |
1,526 |
$32K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
841 |
715 |
$24K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
168 |
166 |
$12K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
128 |
125 |
$11K |
| 36415 |
Collection of venous blood by venipuncture |
3,863 |
3,446 |
$10K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
181 |
171 |
$10K |
| 90756 |
|
427 |
408 |
$8K |
| 0223U |
|
28 |
28 |
$8K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
695 |
659 |
$7K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
227 |
205 |
$7K |
| 93000 |
|
756 |
717 |
$6K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,080 |
857 |
$6K |
| 81002 |
|
4,443 |
4,166 |
$4K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
66 |
64 |
$3K |
| 99205 |
Prolong outpt/office vis |
41 |
41 |
$3K |
| 99497 |
|
189 |
177 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
503 |
429 |
$2K |
| 90688 |
|
112 |
112 |
$1K |
| 82947 |
|
1,277 |
1,089 |
$832.63 |
| 90694 |
|
70 |
69 |
$788.78 |
| 90686 |
|
70 |
70 |
$727.07 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
62 |
52 |
$519.70 |
| 90653 |
|
34 |
34 |
$500.58 |
| 90661 |
|
17 |
17 |
$429.95 |
| 99483 |
Prolong outpt/office vis |
24 |
16 |
$392.19 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
44 |
44 |
$354.23 |
| 99490 |
Ccm add 20min |
1,448 |
1,246 |
$333.64 |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
25 |
24 |
$262.06 |
| 83037 |
|
556 |
540 |
$240.39 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
105 |
101 |
$193.18 |
| 99072 |
|
580 |
521 |
$71.25 |
| G0008 |
Administration of influenza virus vaccine |
73 |
73 |
$49.25 |
| 96116 |
|
17 |
14 |
$44.86 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
17 |
13 |
$41.48 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
59 |
38 |
$17.36 |
| 81000 |
|
13 |
13 |
$16.05 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
20 |
20 |
$0.00 |
| 3288F |
|
28 |
27 |
$0.00 |